Page 20 - Global Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Mar 14, 2026

Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

3,015 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
QURE	US$15.53	8.8%	9.4%	US$971.1m	US$38.47	60.3	35.8%	n/a
A000100	₩99,300.00	0%	-20.4%	₩7.4t	₩147,052.63	110.3	35.8%	0.5%
2332	CN¥9.08	-0.4%	-9.7%	CN¥9.0b	CN¥13.32	32.8	35.5%	2.2%
688131	CN¥65.85	5.0%	59.5%	CN¥14.0b	CN¥94.00	56.4	35.2%	0.3%
PHM	€78.75	-2.1%	-12.3%	€1.4b	€98.88	39.9	35.0%	1.0%
FULC	US$7.65	-6.4%	145.2%	US$509.5m	US$19.00	1.5	35.0%	n/a
2019	CN¥14.45	8.9%	28.2%	CN¥15.0b	CN¥18.00	36.8	34.8%	0%
A237690	₩160,700.00	0.4%	112.6%	₩3.3t	₩158,888.89	90.5	34.5%	0.3%
ALVO	US$3.47	-13.5%	-69.3%	US$1.1b	US$18.83	15.6	34.4%	n/a
OGN	US$6.35	-3.2%	-58.5%	US$1.7b	US$9.00	8.8	34.4%	1.3%
BRKR	US$33.75	-8.0%	-26.6%	US$5.1b	US$48.43	1.5	34.3%	0.6%
IOBT	US$0.19	-36.3%	-78.2%	US$13.8m	US$2.18	15.1	34.2%	n/a
GPCR	US$53.75	-6.9%	155.3%	US$3.8b	US$108.93	2.5	34.2%	n/a
EYPT	US$13.20	-16.2%	102.5%	US$1.1b	US$37.42	35.1	34.1%	n/a
SHC	US$13.42	-8.5%	15.7%	US$3.8b	US$20.75	48.9	34.1%	n/a
RCUS	US$21.97	-0.6%	135.2%	US$2.8b	US$33.80	11.1	34.0%	n/a
BONEX	SEK 196.10	-0.5%	-42.5%	SEK 13.1b	SEK 366.60	92.1	34.0%	n/a
A068270	₩205,500.00	-3.3%	14.8%	₩45.0t	₩253,958.33	61.0	34.0%	0.4%
JAZZ	US$178.55	-1.9%	29.4%	US$11.0b	US$222.69	2.6	33.8%	n/a
300347	CN¥55.11	-3.9%	-5.3%	CN¥44.9b	CN¥67.77	77.0	33.8%	0.5%
IVACC	SEK 0.73	8.5%	-24.2%	SEK 249.1m	SEK 2.20	12.4	33.8%	n/a
CHRS	US$1.63	-10.4%	77.2%	US$244.3m	US$6.75	5.8	33.7%	n/a
LQDA	US$36.66	1.7%	154.1%	US$3.2b	US$49.89	20.4	33.4%	n/a
KNSA	US$45.78	-0.8%	102.5%	US$3.5b	US$57.38	59.4	33.4%	n/a

Page 20 of 126